Abridge, a pioneer in generative AI for healthcare, has secured $30 million in Series B funding, led by Spark Capital, with participation from prominent healthcare innovators such as Mayo Clinic, Kaiser Permanente Ventures, CVS Health Ventures, and more. Abridge’s generative AI scribe instantly transforms patient-clinician conversations into structured clinical notes, saving clinicians over two hours daily in administrative tasks. Over 91% of notes across 40 specialties are autonomously drafted by their AI. The funding will support widespread health system adoption and further product enhancements, enhancing patient care while preserving clinician work-life balance.
Abridge, a company leading the way in generative AI for healthcare raises $30M in Series B funding led by Spark Capital, along with several leading healthcare innovators, including Mayo Clinic, Kaiser Permanente Ventures, CVS Health Ventures, UC Investments, Lifepoint Health, SCAN Health Plan, and the American College of Cardiology.
Abridge’s generative AI scribe automatically converts a patient-clinician conversation into a structured clinical note draft in real time, leveraging their proprietary AI pipeline.
“I want to care for patients, not paperwork.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The solution has been proven to save clinicians over two hours per day from administrative burdens that previously took time away from patients and detracted from clinician work-life balance. In recent implementations, over 91% of notes across over 40 specialties were drafted solely with their AI, requiring minimal input from the clinician. The solution has been uniquely designed with trust and auditability, providing the ability to quickly see source data from any AI-generated summary.
Expansion Plans
The company plans to use the latest round of funding to support large-scale health system rollouts and accelerate product advances that will create additional value for patients, clinicians, and health systems.
“The investment and support of these iconic institutions is a game-changer for Abridge, dramatically accelerating what we can do to solve a critical issue facing every health system,” said Dr. Shiv Rao, co-founder and CEO of Abridge. “We are grateful to have an extraordinary and rapidly expanding group of partners who share our ambition to preserve the empathy and humanity in healthcare by enabling clinicians to be more present with their patients.”
Source: Hitconsultant
